βTrCP- and Rsk1/2-Mediated Degradation of BimEL Inhibits Apoptosis

被引:156
作者
Dehan, Elinor [2 ]
Bassermann, Florian [2 ]
Guardavaccaro, Daniele [2 ]
Vasiliver-Shamis, Gaia [2 ]
Cohen, Michael [4 ]
Lowes, Kym N. [5 ]
Dustin, Michael [2 ]
Huang, David C. S. [5 ]
Taunton, Jack [3 ,4 ]
Pagano, Michele [1 ,2 ]
机构
[1] NYU, Howard Hughes Med Inst, Sch Med, New York, NY 10016 USA
[2] NYU, Inst Canc, Dept Pathol, New York, NY 10016 USA
[3] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA
[4] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA
[5] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia
基金
澳大利亚国家健康与医学研究理事会; 美国国家卫生研究院; 英国医学研究理事会;
关键词
REGULATED KINASES 1/2; BCL-2; FAMILY; HOMOZYGOUS DELETIONS; PROTEIN BIM; PHOSPHORYLATION; PROMOTES; CELLS; IDENTIFICATION; SUPPRESSOR; IMATINIB;
D O I
10.1016/j.molcel.2008.12.020
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The BimEL tumor suppressor is a potent proapoptotic BH3-only protein. We found that, in response to survival signals, BimEL was rapidly phosphorylated on three serine residues in a conserved degron, facilitating binding and degradation via the F box protein beta TrCP. Phosphorylation of the BimEL degron was executed by Rsk1/2 and promoted by the Erk1/2-mediated phosphorylation of BimEL on Ser69. Compared to wild-type BimEL, a BimEL phosphorylation mutant unable to bind beta TrCP was stabilized and consequently potent at inducing apoptosis by the intrinsic mitochondrial pathway. Moreover, although non-small cell lung cancer (NSCLC) cells often become resistant to gefitinib (a clinically relevant tyrosine kinase inhibitor that induces apoptosis through BimEL), silencing of either beta TrCP or Rsk1/2 resulted in BimEL-mediated apoptosis of both gefitinib-sensitive and gefitinib-insensitive NSCLC cells. Our findings reveal that beta TrCP promotes cell survival in cooperation with the ERK-RSK pathway by targeting BimEL for degradation.
引用
收藏
页码:109 / 116
页数:8
相关论文
共 31 条
[1]   Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim [J].
Akiyama, T ;
Bouillet, P ;
Miyazaki, T ;
Kadono, Y ;
Chikuda, H ;
Chung, UG ;
Fukuda, A ;
Hikita, A ;
Seto, H ;
Okada, T ;
Inaba, T ;
Sanjay, A ;
Baron, R ;
Kawaguchi, H ;
Oda, H ;
Nakamura, K ;
Strasser, A ;
Tanaka, S .
EMBO JOURNAL, 2003, 22 (24) :6653-6664
[2]   The RSK family of kinases: emerging roles in cellular signalling [J].
Anjum, Rana ;
Blenis, John .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2008, 9 (10) :747-758
[3]   Imatinib and nilotinib induce apoptosis of chronic myeloid leukemia cells through a Bim-dependant pathway modulated by cytokines [J].
Belloc, Francis ;
Moreau-Gaudry, Francois ;
Uhalde, Maialen ;
Cazalis, Laurie ;
Jeanneteau, Marie ;
Lacombe, Francis ;
Praloran, Vincent ;
Mahon, Francois-Xavier .
CANCER BIOLOGY & THERAPY, 2007, 6 (06) :912-919
[4]   SCFFbxl3 controls the oscillation of the circadian clock by directing the degradation of cryptochrome proteins [J].
Busino, Luca ;
Bassermann, Florian ;
Maiolica, Alessio ;
Lee, Choogon ;
Nolan, Patrick M. ;
Godinho, Sofia I. H. ;
Draetta, Giulio F. ;
Pagano, Michele .
SCIENCE, 2007, 316 (5826) :900-904
[5]   Structural bioinformatics-based design of selective, irreversible kinase inhibitors [J].
Cohen, MS ;
Zhang, C ;
Shokat, KM ;
Taunton, J .
SCIENCE, 2005, 308 (5726) :1318-1321
[6]   BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations [J].
Costa, Daniel B. ;
Halmos, Balazs ;
Kumar, Amit ;
Schumer, Susan T. ;
Huberman, Mark S. ;
Boggon, Titus J. ;
Tenen, Daniel G. ;
Kobayashi, Susumu .
PLOS MEDICINE, 2007, 4 (10) :1669-1680
[7]   Gefitinib-induced killing of NSCLC cell lines expressing mutant EGFR requires BIM and can be enhanced by BH3 mimetics [J].
Cragg, Mark S. ;
Kuroda, Junya ;
Puthalakath, Hamsa ;
Huang, David C. S. ;
Strasser, Andreas .
PLOS MEDICINE, 2007, 4 (10) :1681-1690
[8]   Proapoptotic BH3-only BCL-2 family protein BIM connects death signaling from epidermal growth factor receptor inhibition to the mitochondrion [J].
Deng, Jing ;
Shimamura, Takeshi ;
Perera, Samanthi ;
Carlson, Nicole E. ;
Cai, Dongpo ;
Shapiro, Geoffrey I. ;
Wong, Kwok-Kin ;
Letai, Anthony .
CANCER RESEARCH, 2007, 67 (24) :11867-11875
[9]   BH3 profiling identifies three distinct classes of apoptotic blocks to predict response to ABT-737 and conventional chemotherapeutic agents [J].
Deng, Jing ;
Carlson, Nicole ;
Takeyama, Kunihiko ;
Dal Cin, Paola ;
Shipp, Margaret ;
Letai, Anthony .
CANCER CELL, 2007, 12 (02) :171-185
[10]   S6K1- and βTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth [J].
Dorrello, N. Valerio ;
Peschiaroli, Angelo ;
Guardavaccaro, Daniele ;
Colburn, Nancy H. ;
Sherman, Nicholas E. ;
Pagano, Michele .
SCIENCE, 2006, 314 (5798) :467-471